the biopharmaceutical product. A raw material/excipient should be selected and used according to the assessed level of risk for the particular appliion. Excipients/Raw Materials Used in the Manufacturing Process and Final Formulation of a Biopharmaceutical Product Risk assessment should include the following considerations: Bioburden standards
The cost of raw material is less. Can be performed by semiskilled labor. Can be mechanized easily. Faster production rate. Demerits of CO2 Molding: Not suitable for nonferrous material. The minor fault can lead to gas defects and poor surface finish. Sand Casting Process: Sand casting is the widely used method of casting.